| CAS No. | 1118567-05-7 |
|---|---|
| MDL No. | N/A |
| MF | C24H29ClO7 |
| MW | 464.90 |
| InChI Key | BTCRKOKVYTVOLU-SJSRKZJXSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 99% | $30 | In Stock | |
| 100 mg | 99% | $39 | In Stock | |
| 250 mg | 99% | $67 | In Stock | |
| 1 g | 99% | $94 | In Stock | |
| 5 g | 99% | $185 | In Stock | |
| 10 g | 99% | $277 | In Stock | |
| 25 g | 99% | $441 | In Stock | |
| 50 g | 99% | $659 | In Stock | |
| 100 g | 99% | $1097 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Bexagliflozin is a C-glycosyl compound consisting of beta-D-glucose with the anomeric hydroxy group replaced by a 4-chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl group. It is an SGLT2 inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It functions as a sodium-glucose transport protein subtype 2 inhibitor, hypoglycemic agent, and antihypertensive agent. It is also a C-glycosyl compound, aromatic ether, monochlorobenzene, diether, and member of cyclopropanes.
| CAS No. | 1118567-05-7 |
|---|---|
| Product Name | Bexagliflozin |
| Heavy Atom Count | 32 | Rotatable Bond Count | 9 |
| Atom Stereo Count | 5 | Bond Stereo Count | 0 |
| HBA | 7 | HBD | 4 |
| TPSA | 108.610 Ų | Charge | 0 |
| Exact Mass | 464.16018 | Complexity | 884.42 |
| pKa | 7.765 | XLogP | 2.004 |
